ORANGE COUNTY EARNINGS
- Share via
PharmaPrint Inc.: The Irvine developer of dietary supplement products and pharmaceuticals posted a net loss of $4.3 million, or 39 cents a share, for the third fiscal quarter ended Dec. 31, compared with a year-earlier net loss of $2 million, or 18 cents a share. The nine-month net loss was $12.5 million or $1.13 a share, compared with a net loss of $9 million, or 93 cents a share, for the like three quarters of the previous year. The 1997 figure included $3.8 million in stock compensation expense charges, compared with $5 million in the 1996 period. No revenue was reported.
More to Read
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.